# Moderna, Inc. (MRNA) MD&A by fiscal year

Verbatim Item 7 Management's Discussion and Analysis sections from Moderna, Inc.'s 10-K filings, one page per fiscal year. Extracted from SEC filings with the same bounded parser for every year. Filer text, not grepcent analysis or investment advice.

- [FY 2025 MD&A](/company/MRNA/mda/fy2025/): filed 2026-02-20; accession 0001682852-26-000033 (https://www.sec.gov/Archives/edgar/data/1682852/000168285226000033/mrna-20251231.htm); latest 10-K
- [FY 2024 MD&A](/company/MRNA/mda/fy2024/): filed 2025-02-21; accession 0001682852-25-000022 (https://www.sec.gov/Archives/edgar/data/1682852/000168285225000022/mrna-20241231.htm)
- [FY 2023 MD&A](/company/MRNA/mda/fy2023/): filed 2024-02-23; accession 0001682852-24-000015 (https://www.sec.gov/Archives/edgar/data/1682852/000168285224000015/mrna-20231231.htm)
- [FY 2022 MD&A](/company/MRNA/mda/fy2022/): filed 2023-02-24; accession 0001682852-23-000011 (https://www.sec.gov/Archives/edgar/data/1682852/000168285223000011/mrna-20221231.htm)
- [FY 2021 MD&A](/company/MRNA/mda/fy2021/): filed 2022-02-25; accession 0001682852-22-000012 (https://www.sec.gov/Archives/edgar/data/1682852/000168285222000012/mrna-20211231.htm)

Back to /company/MRNA/